Stock Split History
ETFs Holding HALO »    HALO Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Halozyme Therapeutics is a biopharma technology platform company that provides solutions to improve patient experience and outcomes. Co.'s approved product and its collaborators' approved products and product candidates are based on rHuPH20, its patented recombinant human hyaluronidase enzyme. Co. refers to the application of rHuPH20 to facilitate the delivery of other drugs or fluids as its ENHANZE® Drug Delivery Technology (ENHANZE). Co. licenses the ENHANZE technology to form collaborations with biopharmaceutical companies that develop or market drugs requiring or benefiting from injection via the subcutaneous route of administration. According to our Halozyme Therapeutics stock split history records, Halozyme Therapeutics has had 0 splits.
Halozyme Therapeutics stock split history picture
Halozyme Therapeutics (HALO) has 0 splits in our Halozyme Therapeutics stock split history database.

Looking at the Halozyme Therapeutics stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Halozyme Therapeutics shares, starting with a $10,000 purchase of HALO, presented on a split-history-adjusted basis factoring in the complete Halozyme Therapeutics stock split history. Halozyme Therapeutics split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 05/18/2011
End date: 05/17/2021
Start price/share: $6.48
End price/share: $42.42
Dividends collected/share: $0.00
Total return: 554.63%
Average Annual Total Return: 20.66%
Starting investment: $10,000.00
Ending investment: $65,475.70
Years: 10.01
Date Ratio
LM Funding America, Inc. (LMFA)
Foxby Corp. (XFXBX)
InspireMD, Inc. (NSPR)
Aviat Networks, Inc. (AVNW)
Guardion Health Sciences, Inc. (GHSI)
China SXT Pharmaceuticals, Inc. (SXTC)
VYNE Therapeutics Inc. (VYNE)
The Sherwin-Williams Company (SHW)
Horizons US Marijuana Index ETF (HMUS)
MicroSectors FANG+ ETNs due January 8, 2038 (FNGS)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »
Funds Holding Halozyme Therapeutics
Halozyme Therapeutics Insider Buying

Halozyme Therapeutics Stock Split History | www.StockSplitHistory.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.StockSplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.